Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TO-O-1007 in Geographic Atrophy Secondary to AMD
NCT07668804Phase 2Recruiting
- Sponsor
- TheratOcular Biotek
- Start
- Jun 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of TO-O-1007 in geographic atrophy (GA), sponsored by TheratOcular Biotek. Started Jun 2026; status: recruiting.
02
Drugs
TO-O-1007
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT07668804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668804.